Supernus Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 9,621 | 0.1% | 193,572 | 12/31/2025 |
| 2025 Q3 | 10/31/2025 | 9,523 | 0.1% | 199,259 | 9/30/2025 |
| 2025 Q2 | 7/29/2025 | 6,704 | 0.1% | 212,691 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 6,614 | 0.1% | 201,965 | 3/31/2025 |
| 2024 Q4 | 2/5/2025 | 7,307 | 0.1% | 202,079 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 6,319 | 0.1% | 202,654 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 7,448 | 0.1% | 278,436 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 10,947 | 0.1% | 320,920 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 9,773 | 0.1% | 337,707 | 12/31/2023 |
| 2023 Q3 | 11/9/2023 | 9,542 | 0.1% | 346,115 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 10,457 | 0.1% | 347,885 | 6/30/2023 |
| 2023 Q1 | 5/4/2023 | 12,753 | 0.2% | 352,009 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 13,009 | 0.2% | 364,699 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 12,690 | 0.2% | 374,901 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 11,069 | 0.1% | 382,744 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 11,839 | 0.1% | 366,292 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 10,862 | 0.1% | 372,509 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 10,010 | 0.1% | 375,332 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 9,739 | 0.1% | 316,301 | 6/30/2021 |
| 2021 Q1 | 5/13/2021 | 9,184 | 0.1% | 350,784 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 8,963 | 0.1% | 356,225 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 7,470 | 0.1% | 358,466 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 9,080 | 0.1% | 382,296 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 6,079 | 0.1% | 337,935 | 3/31/2020 |
| 2019 Q4 | 2/11/2020 | 9,418 | 0.1% | 397,029 | 12/31/2019 |
| 2014 Q2 | 8/7/2014 | 8,843 | 0.2% | 807,563 | 6/30/2014 |
| 2014 Q1 | 5/9/2014 | 9,406 | 0.2% | 1,052,150 | 3/31/2014 |
| 2013 Q4 | 2/5/2014 | 7,933 | 0.2% | 1,052,150 | 12/31/2013 |